argenx SE

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

The submission of this form does not create an attorney-client relationship.

Investigation Details

On December 20, 2023, Investor’s Business Daily reported that argenx ‘s “stock crashed early Wednesday after its treatment for an autoimmune disease that causes skin blisters flopped in a Phase 3 study.” Based on this news, shares of the Company’s stock were down by more than 25% in intraday trading on the same day.